SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
231 hedge funds and large institutions have $260M invested in Sorrento Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
231
Holders Change
+4
Holders Change %
+1.76%
% of All Funds
3.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
27
Increased
77
Reduced
42
Closed
20
Calls
$8.55M
Puts
$2.43M
Net Calls
+$6.12M
Net Calls Change
-$1.76M
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$2.87M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.54M |
| 3 |
Rafferty Asset Management
New York
|
+$1.95M |
| 4 |
Goldman Sachs
New York
|
+$1.68M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.58M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$2.94M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.42M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.29M |
| 4 |
SG Americas Securities
New York
|
-$568K |
| 5 |
Jane Street
New York
|
-$562K |
